Product NDC: | 0074-6305 |
Proprietary Name: | EryPed 400 |
Non Proprietary Name: | Erythromycin Ethylsuccinate |
Active Ingredient(s): | 400 mg/5mL & nbsp; Erythromycin Ethylsuccinate |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-6305 |
Labeler Name: | Abbott Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050207 |
Marketing Category: | NDA |
Start Marketing Date: | 20101201 |
Package NDC: | 0074-6305-13 |
Package Description: | 100 mL in 1 BOTTLE (0074-6305-13) |
NDC Code | 0074-6305-13 |
Proprietary Name | EryPed 400 |
Package Description | 100 mL in 1 BOTTLE (0074-6305-13) |
Product NDC | 0074-6305 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin Ethylsuccinate |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20101201 |
Marketing Category Name | NDA |
Labeler Name | Abbott Laboratories |
Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
Strength Number | 400 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |